Send me a link:

*Text messaging rates may apply.

 Dow Down 0.72% Nasdaq Down 0.50%

BioMarin Pharmaceutical Inc. (BMRN)

-NasdaqGS
60.60 Down 0.86(1.40%) Jul 25, 4:00PM EDT
Prev Close:61.46
Open:61.40
Bid:59.00 x 100
Ask:62.00 x 300
1y Target Est:82.38
Beta:0.55
Next Earnings Date:30-Jul-14BMRN Earnings announcement
Day's Range:60.08 - 61.59
52wk Range:55.04 - 84.25
Volume:955,183
Avg Vol (3m):1,287,150
Market Cap:8.84B
P/E (ttm):N/A
EPS (ttm):-1.24
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BMRNDown 1.40%8.84B
FOLDUp 4.46%286.31M
SHPGDown 0.11%49.39B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):15.68
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.72
Quarterly EPS Est (Jun-14) :-0.41
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):-1.41

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BioMarin Pharmaceutical Inc. develops and commercializes biopharmaceuticals for serious diseases and medical conditions in the United States, Europe, Latin America, and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback